Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer

BACKGROUND: Treatment with gemcitabine/nab-paclitaxel confers a survival benefit over gemcitabine monotherapy in patients with advanced pancreatic cancer (APC). However, such treatment can be associated with significant toxicities especially in older patients and carries practical disadvantages rela...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Therap Adv Gastroenterol
Main Authors: Rehman, Hasan, Chi, Jeffrey, Hakim, Nausheen, Goyal, Shreya Prasad, Olazagasti, Coral, Jose, Jyothi, Moriarty, Linda, Saif, Muhammad Wasif
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692343/
https://ncbi.nlm.nih.gov/pubmed/33281939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820974912
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker